Revance

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of Revance Therapeutics, Inc. Securities Litigation

SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION TO: ALL PERSONS OR ENTITIES (“PERSONS”) THAT PURCHASED OR OTHERWISE ACQUIRED REVANCE THERAPEUTICS, INC. (“REVANCE” OR THE “COMPANY”) COMMON STOCK DURING THE PERIOD BEGINNING ON JUNE 19, 2014 AND ENDING ON MAY 1, 2015, AND PURSUANT AND/OR TRACEABLE TO THE REGISTRATION STATEMENT AND PROSPECTUS FOR THE COMPANY’S JUNE 19, 2014 PUBLIC OFFERING …